Sir Michael was appointed Knight Grand Cross of the Order of the British Empire (GBE) after more than three decades at the forefront of innovation, development and leadership in the public health sector.

A new targeted treatment for ovarian cancer led to a shrinking of tumours according to the results of a small phase 1 trial presented at the world’s largest cancer conference, the American Society of Clinical Oncology (ASCO) Annual Meeting 2017 in Chicago.